Yu-Hsiang Hsu

Assistant Professor

Institute of Clinical Medicine

Emailbrianhsu@mail.ncku.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2011 PhD, Institute of Clinical Pharmacy and Pharmaceutical Sciences , National Cheng Kung University

Experience

2011-2012, Postdoctoral Fellow/Department of Biochemistry and Molecular Biology, National Cheng Kung University
2012-present, Research Fellow/Antibody New Drug Development Center, National Cheng Kung University
2013-2015, Adjunct Assistant Professor/Department of Biochemistry and Molecular Biology, National Cheng Kung University
2015-present, Assistant Professor/Institute of Clinical Medicine, National Cheng Kung University

Research Interests

Cytokine regulation
Osteoimmunology
New antibody drug development

Fingerprint

Dive into the research topics where Yu-Hsiang Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

3 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
5 Finished

介白素二十九在肥胖誘導之發炎及胰島素抗性中的調控角色
Hsu, Y.
19-08-01 → 20-07-31
Project: Research project
評估阻斷介白素二十及其接受器在退化性關節炎小鼠模式中的療效
Hsu, Y.
17-08-01 → 18-07-31
Project: Research project
探討介白素二十調控軟骨細胞分化及在發炎性骨頭疾病中的角色
Hsu, Y.
16-08-01 → 17-07-31
Project: Research project
探討介白素二十調控軟骨細胞分化及在發炎性骨頭疾病中的角色
Hsu, Y.
15-08-01 → 16-07-31
Project: Research project
研究介白素二十及其接受器在糖尿病發病機制的角色
Hsu, Y.
14-08-01 → 15-07-31
Project: Research project

572 Citations
13 h-Index
23 Article
6 Review article

Anti-IL-20 antibody improved motor function and reduced glial scar formation after traumatic spinal cord injury in rats
Lee, J. S., Hsu, Y. H., Chiu, Y. S., Jou, I. M. & Chang, M. S., 2020 May 14, In: Journal of Neuroinflammation. 17, 1, 156.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models
Lu, S. W., Pan, H. C., Hsu, Y. H., Chang, K. C., Wu, L. W., Chen, W. Y. & Chang, M. S., 2020 Dec 1, In: Nature communications. 11, 1, 4611.
Research output: Contribution to journal › Article › peer-review

Open Access
Il-20 in acute kidney injury: Role in pathogenesis and potential as a therapeutic target
Lin, T. Y. & Hsu, Y. H., 2020 Feb 1, In: International journal of molecular sciences. 21, 3, 1009.
Research output: Contribution to journal › Review article › peer-review

Open Access
3 Citations (Scopus)
IL-29 promoted obesity-induced inflammation and insulin resistance
Lin, T. Y., Chiu, C. J., Kuan, C. H., Chen, F. H., Shen, Y. C., Wu, C. H. & Hsu, Y. H., 2020 Apr 1, In: Cellular and Molecular Immunology. 17, 4, p. 369-379 11 p.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy
Chen, L. H., Yeh, Y. M., Chen, Y. F., Hsu, Y. H., Wang, H. H., Lin, P. C., Chang, L. Y., Lin, C. C. K., Chang, M. S. & Shen, M. R., 2020 Jun 1, In: Pain. 161, 6, p. 1237-1254 18 p.
Research output: Contribution to journal › Article › peer-review